Speed kills: Cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis

FASEB Journal

Volumn 17, Issue 13, 2003, Pages 1775-1788

  Cadet, Jean Lud ^a   Jayanthi, Subramaniam ^a   Deng, Xiaolin ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bcl 2 family proteins; cDNA array; Endoplasmic reticulum; IEGs; Mitochondria; Neurodegeneration; Terminal apoptosis

Indexed keywords

CASPASE; METHAMPHETAMINE; OXYGEN RADICAL; TRANSCRIPTION FACTOR;

APOPTOSIS; BRAIN MITOCHONDRION; DRUG ABUSE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; MONOAMINERGIC SYSTEM; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE ENDING; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; CYTOPROTECTION; HUMANS; METHAMPHETAMINE; MICE; MODELS, BIOLOGICAL; NERVE DEGENERATION; NEURONS; NEUROTOXICITY SYNDROMES; PRESYNAPTIC TERMINALS; RATS; SIGNAL TRANSDUCTION;

MAMMALIA; RODENTIA;

EID: 0141445982     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-0073rev     Document Type: Review

References (208)

1. Derlet, R. W., Rice, P., Horowitz, B. Z., and Lord, R. V. (1989) Amphetamine toxicity: experience with 127 cases. J. Emerg. Med. 7, 157-161
2. Puder, K. S., Kagan, D. V., and Morgan, J. P. (1988) Illicit methamphetamine: analysis, synthesis, and availability. Am. J. Drug Alcohol Abuse 14, 463-473
3. Perez, J. A., Jr., Arsura, E. L., and Strategos, S. (1999) Methamphetamine-related stroke: four cases. J. Emerg. Med. 17, 469-471
4. Lan, K. C., Lin, Y. F., Yu, F. C., Lin, C. S., and Chu, P. (1998) Clinical manifestations and prognostic features of acute methamphetamine intoxication. J. Fornos. Med. Assoc. 97, 528-533
5. Stewart, J. L., and Meeker, J. E. (1997) Fetal and infant deaths associated with maternal methamphetamine abuse. J. Anal. Toxicol. 21, 515-517
6. Ellinwood, E. H., and Cohen, S. (1971) Amphetamine abuse. Science 171, 420-421
7. Kalant, H., and Kalant, O. J. (1975) Death in amphetamine users: causes and rates. Can. Med. Assoc. J. 112, 299-304
8. Logan, B. K. (2001) Amphetamines: an update on forensic issues. J. Anal. Toxicol. 25, 400-404
9. Schepens, P. J., Pauwels, A., Van Damme, P., Musuku, A., Beaucourt, L., and Selala, M. I. (1998) Drugs of abuse and alcohol in weekend drivers involved in car crashes in Belgium. Ann. Emerg. Med. 31, 633-637
10. Vega, W. A., Gil, A., Warheit, G., Apospori, E., and Zimmerman, R. (1993) The relationship of drug use to suicide ideation and attempts among African American, Hispanic, and white non-Hispanic male adolescents. Suicide Life Threat. Behav. 23, 110-119
11. Simon, S. L., Domier, C., Carnell, J., Brethen, P., Rawson, R., and Ling, W. (2000) Cognitive impairment in individuals currently using methamphetamine. Am. J. Addict. 9, 222-231
12. Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., and Kish, S. J. (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2, 699-703
13. Yui, K., Goto, K., Ikemoto, S., Ishiguro, T., Angrist, B., Duncan, G. E., Sheitman, B. B., Lieberman, J. A., Bracha, S. H., and Ali, S. F. (1999) Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Mol. Psychiatry 4, 512-523
14. Kramer, J. C., Fischman, V. S., and Littlefield, D. C. (1967) Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA 201, 305-309
15. Volkow, N. D., Chang, L., Wang, G.J., Fowler, J. S., Franceschi, D., Sedler, M.J., Gatley, S.J., Hitzemann, R., Ding, Y. S., Wong, C., et al. (2001) Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am. J. Psychiatry 158, 383-389
16. Conci, F., D'Angelo, V., Tampieri, D., and Vecchi, G. (1988) Intracerebral hemorrhage and angiographic beading following amphetamine abuse, Ital. J. Neurol. Sci. 9, 77-81
17. Hall, W., Hando, J., Darke, S., and Ross, J. (1996) Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 91, 81-87
18. Chynn, K. Y. (1968) Technique for experimental embolization of cerebral arteries and repetitive selective internal carotid arteriography in dogs. Invest. Radiol. 3, 275-279
19. Salanova, V., and Taubner, R., (1984) Intracerebral haemorrhage and vasculitis secondary to amphetamine use. Postgrad. Med. J. 60, 429-430
20. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y. S., et al. (2001) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21, 9414-9418
21. McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., and Ricaurte, G. A. (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 18, 8417-8422
22. Volkow, N. D., Chang, L., Wang, G.J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y. S., et al. (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158, 377-382
23. Ernst, T., Chang, L., Leonido-Yee, M., and Speck, O. (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology, 54, 1344-1349
24. Connell, P. H. (1968) Amphetamine dependence. Proc. R. Soc. Med. 61, 178-181
25. Cho, A. K., Melega, W. P., Kuczenski, R., and Segal, D. S. (2001) Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39, 161-166
26. Marek, G. J., Vosmer, G., and Seiden, L. S. (1990) The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat. Brain Res. 516, 1-7
27. Marek, G. J., Vosmer, G., and Seiden, L. S. (1990) Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats. Pharmacol. Biochem. Behav. 36, 187-190
28. Seiden, L. S., and Vosmer, G. (1984) Formation of 6-hydroxy-dopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 21, 29-31
29. Cappon, G. D., Pu, C., and Vorhees, C. V. (2000) Time-course of methamphetamine-induced neurotoxicity in rat caudateputamen after single-dose treatment. Brain Res. 863, 106-111
30. Fukumura, M., Cappon, G. D., Pu, C., Broening, H. W., and Vorhees, C. V. (1998) A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res. 806, 1-7
31. Sonsalla, P. K., Gibb, J. W., and Hanson, G. R. (1986) Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J. Pharmacol. Exp. Ther. 238, 932-937
32. Sonsalla, P. K., Gibb, J. W., and Hanson, G. R. (1986) Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system. Neuropharmacology 25, 1221-1230
33. Kogan, F. J., Nichols, W. K., and Gibb, J. W. (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36, 363-371
34. Hotchkiss, A. J., and Gibb, J. W. (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257-262
35. Chapman, D. E., Hanson, G. R., Kesner, R. P., and Keefe, K. A. (2001) Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J. Pharmacol. Exp. Ther. 296, 520-527
36. Hayashi, T., Hirata, H., Asanuma, M., Ladenheim, B., Tsao, L. I., Cadet, J. L., and Su, T. P. (2001) Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53. Synapse 39, 305-312
37. Chan, P., Di Monte, D. A., Luo, J.J., DeLanney, L. E., Irwin, I., and Langston, J. W. (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62, 2484-2487
38. Sonsalla, P. K., and Heikkila, R. E. (1988) Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 12, 345-354
39. O'Callaghan, J. P., and Miller, D. B. (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 741-751
40. Ricaurte, G. A., and McCann, U. D. (1992) Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann. N.Y. Acad. Sci. 648, 371-382
41. Woolverton, W. L., Ricaurte, G. A., Forno, L. S., and Seiden, L. S. (1989) Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486, 73-78
42. Villemagne, V., Yuan, J., Wong, D. F., Dannals, R. F., Hatzidimitriou, G., Mathews, W. B., Ravert, H. T., Musachio, J., McCann, U. D., and Ricaurte, G. A. (1998) Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J. Neurosci. 18, 419-427
43. Ricaurte, G. A., Seiden, L. S., and Schuster, C. R. (1983) Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine. Neuropharmacology 22, 1383-1388
44. Cadet, J. L., Mi, S., and Epstein, C. (1994) Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice. Ann. N.Y. Acad. Sci. 738, 388-391
45. Wagner, G. C., Ricaurte, G. A., Johanson, C. E., Schuster, C. R., and Seiden, L. S. (1980) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30, 547-550
46. Hotchkiss, A., and Gibb, J. W. (1980) Blockade of methamphetamine-induced depression of tyrosine hydroxylase by GABA transaminase inhibitors. Eur. J. Pharmacol. 66, 201-205
47. Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., and Moore, R. Y. (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235, 93-103
48. Steranka, L. R., and Sanders-Bush, E. (1980) Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. Eur. J. Pharmacol. 65, 439-443
49. Nakayama, M., Koyama, T., and Yamashita, I. (1993) Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum. Brain Res. 601, 209-212
50. Frey, K., Kilbourn, M., and Robinson, T. (1997) Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur. J. Pharmacol. 334, 273-279
51. Fleckenstein, A. E., Metzger, R. R., Wilkins, D. G., Gibb, J. W., and Hanson, G. R. (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282, 834-838
52. Kokoshka, J. M., Vaughan, R. A., Hanson, G. R., and Fleckenstein, A. E. (1998) Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. Eur. J. Pharmacol. 361, 269-275
53. Fleckenstein, A. E., Haughey, H. M., Metzger, R. R., Kokoshka, J. M., Riddle, E. L., Hanson, J. E., Gibb, J. W., and Hanson, G. R. (1999) Differential effects of psychostimulants ants and related agents on dopaminergic and serotonergic transporter function. Eur. J. Pharmacol. 382, 45-49
54. Teuchert-Noodt, G., and Dawirs, R. R. (1991) Age-related toxicity in prefrontal cortex and caudate-putamen complex of gerbils (Meriones unguiculatus) after a single dose of methamphetamine. Neuropharmacology 30, 733-743
55. Miller, D. B., O'Callaghan, J. P., and Ali, S. F. (2000) Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Ann. N.Y. Acad. Sci. 914, 194-207
56. Imam, S. Z., and Ali, S. F. (2001) Aging increases the susceptibility to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia. J. Neurochem. 78, 952-959
57. Pu, C., and Vorhees, C. V. (1993) Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res. Dev. Brain Res. 72, 325-328
58. Kokoshka, J. M., Fleckenstein, A. E., Wilkins, D. G., and Hanson, G. R. (2000) Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine, J. Neurochem. 75, 2095-2102
59. 3H]-5-hydroxytryptamine uptake systems in rat brain regions. Br. J. Pharmacol. 67, 387-391
60. Ali, S. F., Holson, R. R., Newport, G. D., Slikker, W., Jr., and Bowyer, J. F. (1993) Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure. Brain Res. Dev. Brain Res. 73, 25-33
61. Fukui, K., Nakajima, T., Kariyama, H., Kashiba, A., Kato, N., Tohyama, I., and Kimura, H. (1989) Selective reduction of serotonin immunoreactivity in some forebrain regions of rats induced by acute methamphetamine treatment; quantitative morphometric analysis by serotonin immunocytochemistry. Brain Res. 482, 198-203
62. Axt, K. J., and Molliver, M. E. (1991) Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9, 302-313
63. Seiden, L. S., and Sabol, K. E. (1995) Neurotoxicity of methamphetamine and related drugs and cocaine. In Handbook of Neurotoxicology (Chang, L. W., and Dyer, R. S., eds) pp. 825-843, Marcel Dekker, New York
64. Ricaurte, G. A., Fuller, R. W., Perry, K. W., Seiden, L. S., and Schuster, C. R. (1983) Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology 22, 1165-1169
65. Fleckenstein, A. E., Wilkins, D. G., Gibb, J. W., and Hanson, G. R. (1997) Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther. 283, 281-285
66. Fleckenstein, A. E., Beyeler, M. L.,Jackson, J. C., Wilkins, D. G., Gibb, J. W., and Hanson, G. R. (1997) Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters. Eur. J. Pharmacol. 324, 179-186
67. Kokoshka, J. M., Metzger, R. R., Wilkins, D. G., Gibb, J. W., Hanson, G. R., and Fleckenstein, A. E. (1998) Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res. 799, 78-83
68. 3H]serotonin synaptosomal uptake, and serotonin metabolism in rat brain following systemic tryptophan loading. Neuropharmacology 21, 521-527
69. Davidson, C., Gow, A. J., Lee, T. H., and Ellinwood, E. H. (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36, 1-22
70. Cadet, J. L., Ordonez, S. V., and Ordonez, J. V. (1997) Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 25, 176-184
71. Stumm, G., Schlegel, J., Schafer, T., Wurz, C., Mennel, H. D., Krieg, J. C., and Vedder, H. (1999) Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13, 1065-1072
72. Deng, X., and Cadet, J. L. (2000) Methamphetamine-induced apoptosis is attenuated in the striata of copper-zinc superoxide dismutase transgenic mice. Brain Res. 83, 121-124
73. Deng, X., Wang, Y., Chou, J., and Cadet, J. L. (2001) Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. 93, 64-69
74. Jayanthi, S., Deng, X., Bordelon, M., McCoy, M. T., and Cadet, J. L. (2001) Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J. 15, 1745-1752
75. Deng, X., Ladenheim, B., Tsao, L. I., and Cadet, J. L. (1999) Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J. Neurosci. 19, 10107-10115
76. Pu, C., Broening, H. W., and Vorhees, C. V. (1996) Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse 23, 328-334
77. Eisch, A. J., Schmued, L. C., and Marshall, J. F. (1998) Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse 30, 329-333
78. Eisch, A. J., and Marshall, J. F. (1998) Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30, 433-445
79. Schmued, L. C., and Bowyer, J. F. (1997) Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 759, 135-140
80. Sulzer, D., Chen, T. K., Lau, Y. Y., Kristensen, H., Rayport, S., and Ewing, A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102-4108
81. Cubells, J. F., Rayport, S., Rajendran, G., and Sulzer, D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 2260-2271
82. Baldwin, H. A., Colado, M. I., Murray, T. K., De Souza, R. J., and Green, A. R. (1993) Striatal dopamine release in Vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. Br. J. Pharmacol. 108, 590-596
83. Marshall, J. F., O'Dell, S. J., and Weihmuller, F. B. (1993) Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J. Neural Transm. Gen. Sect. 91, 241-254
84. Jones, S. R., Gainetdinov, R. R., Wightman, R. M., and Caron, M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986
85. Marek, G. J., Vosmer, G., and Seiden, L. S. (1990) Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res. 513, 274-279
86. Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., and Caron, M. G. (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18, 4861-4869
87. Fumagalli, F., Gainetdinov, R. R., Wang, Y. M., Valenzano, K. J., Miller, G. W., and Caron, M. G. (1999) Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J. Neurosci. 19, 2424-2431
88. LaVoie, M. J., and Hastings, T. G. (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19, 1484-1491
89. Stokes, A. H., Hastings, T. G., and Vrana, K. E. (1999) Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55, 659-665
90. Cadet, J. L., and Brannock, C. (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32, 117-131
91. De Vito, M.J., and Wagner, G. C. (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28, 1145-1150
92. Giovanni, A., Liang, L. P., Hastings, T. G., and Zigmond, M.J. (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64, 1819-1825
93. Wagner, G. C., Carelli, R. M., and Jarvis, M. F. (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res. Commun. Chem. Pathol. Pharmacol 47, 221-228
94. Cadet, J. L., Sheng, P., Mi, S., Rothman, R., Carlson, E., and Epstein, C. (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62, 380-383
95. Hirata, H., Ladenheim, B., Carlson, E., Epstein, C., and Cadet, J. L. (1996) Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714, 95-103
96. Jayanthi, S., Ladenheim, B., and Cadet, J. L. (1998) Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zino-superoxide dismutase transgenic mice. Ann. N.Y. Acad. Sci. 844, 92-102
97. Jayanthi, S., Ladenheim, B., Andrews, A. M., and Cadet, J. L. (1999) Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy). Neuroscience 91, 1379-1387
98. Fridovich, I. (1997) Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J. Biol. Chem. 272, 18515-18517
99. Gluck, M. R., Moy, L. Y., Jayatilleke, E., Hogan, K. A., Manzino, L., and Sonsalla, P. K. (2001) Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J. Neurochem. 79, 152-160
100. Dugan, L. L., and Choi, D. W. (1994) Excitotoxicity, free radicals, and cell membrane changes. Ann. Neurol. 35, Suppl., S17-S21
101. Dawson, V. L., Dawson, T. M., Bartley, D. A., Uhl, G. R., and Snyder, S. H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci, 13, 2651-2661
102. Beckman, J. S. (1991) The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15, 53-59
103. Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244-4250
104. Cadet, J. L. (2003) Roles of glutamate, nitric oxide, oxidative stress, and apoptosis in the neurotoxicity of methamphetamine. In Gluamate and Addiction (Herman, B. H., ed) pp. 201-210, Humana Press, New Jersey
105. Sonsalla, P. K., Riordan, D. E., and Heikkila, R. E. (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256, 506-512
106. Itzhak, Y., Gandia, C., Huang, P. L., and Mi, S. F. (1998) Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 284, 1040-1047
107. Imam, S. Z., Newport, G. D., Itzhak, Y., Cadet, J. L., Islam, F., Slikker, W., Jr., and Ali, S. F. (2001) Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J. Neurochem. 76, 745-749
108. Itzhak, Y., Martin, J. L., and Ail, S. F. (2000) nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity, but not hyperthermia in mice. NeuroReport 11, 2943-2946
109. Sanchez, V., Zeini, M., Camarero, J., O'Shea, E., Bosca, L., Green, A. R., and Colado, M. I. (2003) The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity, induced by methamphetamine in the mouse striatum. J. Neurochem. 85, 515-524
110. Gamaley, I. A., and Klyubin, L. V. (1999) Roles of reactive oxygen species: signaling and regulation of cellular functions. Int. Rev. Cytol. 188, 203-255
111. Itzhak, Y., Martin, J. L., and Ali, S. F. (2000) Comparison between the role of the neuronal and inducible nitric oxide synthase in methamphetamine-induced neurotoxicity and sensitization. Ann. N.Y. Acad. Sci. 914, 104-111
112. Schuman, E. M., and Madison, D. V. (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254, 1503-1506
113. Everitt, B.J., and Wolf, M. E. (2002) Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 22, 3312-3320
114. Miller, D. B., and O'Callaghan, J. P. (1994) Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 752-760
115. Albers, D. S., and Sonsalla, P. K. (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275, 1104-1114
116. Bowyer, J. F., Davies, D. L., Schmued, L., Broening, H. W., Newport, G. D., Slikker, W., Jr., and Holson, R. R. (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268, 1571-1580
117. Farfel, G. M., and Seiden, L. S. (1995) Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther. 272, 868-875
118. + exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity. J. Neurochem. 77, 1348-1362
119. Krueger, B. K. (1990) Kinetics and block of dopamine uptake in synaptosomes from rat calidate nucleus. J. Neurochem. 55, 260-267
120. Gu, H., Wall, S. C., and Rudnick, G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124-7130
121. Sonders, M. S., Zhu, S. J., Zahniser, N. R., Kavanaugh, M. P., and Amara, S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960-974
122. Koch, R. A., and Barish, M. E. (1994) Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. J. Neurosci. 14, 2585-2593
123. Yurko-Mauro, K. A., and Friedman, E. (1996) Dopamine-stimulated changes in activated calpain I in rat hippocampal slices. J. Neurosci. Res. 43, 476-481
124. Takai, N., Nakanishi, H., Tanabe, K., Nishioku, T., Sugiyama, T., Fujiwara, M., and Yamamoto, K. (1998) Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. J. Neurosci. Res. 54, 214-222
125. Tabner, B.J., Turnbull, S., El-Agnaf, O., and Allsop, D. (2001) Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr. Top. Med. Chem. 1, 507-517
126. Sheng, P., Cerruti, C., Ali, S., and Cadet, J. L. (1996) Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells. Ann. N.Y. Acad. Sci. 801, 174-186
127. Cadet, J. L., Jayanthi, S., McCoy, M. T., Vawter, M., and Ladenheim, B. (2001) Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array. Synapse 41, 40-48
128. Yoshizumi, M., Abe, J., Haendeler, J., Huang, Q., and Berk, B. C. (2000) Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J. Biol. Chem. 275, 11706-11712
129. Jayanthi, S., McCoy, M. T., Ladenheim, B., and Cadet, J. L. (2002) Methamphetamine causes coordinate regulation of SRC, cas, crk, and the jun N-terminal kinase-jun pathway. Mol. Pharmacol. 61, 1124-1131
130. Fukunaga, K., and Miyamoto, E. (1998) Role of MAP kinase in neurons. Mol. Neurobiol. 16, 79-95
131. Minden, A., Lin, A., Smeal, T., Derijard, B., Cobb, M., Davis, R., and Karin, M. (1994) c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14, 6683-6688
132. Karin, M., and Hunter, T. (1995) Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5, 747-757
133. Tournier, C., Whitmarsh, A. J., Cavanagh, J., Barrett, T., and Davis, R.J. (1997) Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA 94, 7337-7342
134. Hebert, M. A., and O'Callaghan, J. P. (2000) Protein phosphorylation cascades associated with methamphetamine-induced glial activation. Ann. N.Y. Acad. Sci. 914, 238-262
135. Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J., and Davis, R. J. (1995) Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267, 682-685
136. Moriguchi, T., Toyoshima, F., Masuyama, N., Hanafusa, H., Gotoh, Y., and Nishida, E. (1997) A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J. 16, 7045-7053
137. Watson, A., Eilers, A., Lallemand, D., Kyriakis, J., Rubin, L. L., and Ham, J. (1998) Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18, 751-762
138. Herdegen, T., Claret, F. X., Kallunki, T., Martin-Villalba, A., Winter, C., Hunter, T., and Karin, M. (1998) Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 18, 5124-5135
139. Deng, X., Jayanthi, S., Ladenheim, B., Krasnova, I. N., and Cadet, J. L. (2002) Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis. Mol. Pharmacol. 62, 993-1000
140. Takaki, M., Ujike, H., Kodama, M., Takehisa, Y., Nakata, K., and Kuroda, S. (2001) Two kinds of mitogen-activated protein kinase phosphatases, MKP-1 and MKP-3, are differentially activated by acute and chronic methamphetamine treatment in the rat brain. J. Neurochem. 79, 679-688
141. Ujike, H., Takaki, M., Kodama, M., and Kuroda, S. (2002) Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann. N.Y. Acad. Sci. 965, 55-67
142. Bokemeyer, D., Sorokin, A., Yan, M., Ahn, N. G., Templeton, D. J., and Dunn, M. J. (1996) Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J. Biol. Chem. 271, 639-642
143. Itzhak, Y., and Ali, S. F. (2002) Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. Ann. N.Y. Acad. Sci. 965, 127-135
144. Itzhak, Y., Martin, J. L., and Ahn, S. F. (2002) Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 1177-1183
145. Reed, J. C. (1996) Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst. Mitt. 72-100
146. Korsmeyer, S. J., Shutter, J. R., Veis, D. J., Merry, D. E., and Oltvai, Z. N. (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4, 327-332
147. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136
148. Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331-1341
149. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P., and Wang, X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132
150. Marzo, I., Brenner, C., Zamzami, N., Susin, S. A., Beutner, G., Brdiczka, D., Remy, R., Xie, Z. H., Reed, J. C., and Kroemer, G. (1998) The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 187, 1261-1271
151. Marchetti, P., Castedo, M., Susin, S. A., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., and Kroemer, G. (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184, 1155-1160
152. Shimizu, S., Eguchi, Y., Kamiike, W., Akao, Y., Kosaka, H., Hasegawa, J., Matsuda, H., and Tsujimoto, Y. (1996) Involvement of ICE family proteases in apoptosis induced by reoxygenation of hypoxic hepatocytes. Am. J. Physiol. 271, G949-G958
153. Satoh, M. S., and Lindahl, T. (1992) Role of poly(ADP-ribose) formation in DNA repair. Nature (London) 356, 356-358
154. Cohen, G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16
155. Allen, R. T., Cluck, M. W., and Agrawal, D. K. (1998) Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell. Mol. Life Sci. 54, 427-445
156. Boyd, J. M., Gallo, G. J., Elangovan, B., Houghton, A. B., Malstrom, S., Avery, B. J., Ebb, R. G., Subramanian, T., Chittenden, T., Lutz, R. J., et al. (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921-1928
157. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619
158. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291
159. Kelekar, A., Chang, B. S., Harlan, J. E., Fesik, S. W., and Thompson, C. B. (1997) Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol. 17, 7040-7046
160. Deng, X., Cai, N. S., McCoy, M. T., Chen, W., Trush, M. A., and Cadet, J. L. (2002) Methamphetamine induces apoptosis in an immortalized rat striatal
161. Ravagnan, L., Roumier, T., and Kroemer, G. (2002) Mitochondria, the killer organelles and their weapons. J. Cell. Physiol. 192, 131-137
162. Marzo, I., Brenner, C., Zamzami, N., Jurgensmeier, J. M., Susin, S. A., Vieira, H. L., Prevost, M. C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027-2031
163. Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R. J., Matsuda, H., and Tsujimoto, Y. (1998) Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 14681-14686
164. Shimizu, S., Narita, M., and Tsujimoto, Y. (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (London) 399, 483-487
165. McCullough, K. D., Martindale, J. L., Klotz, L. O., Aw, T. Y., and Holbrook, N. J. (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 21, 1249-1259
166. Ferri, R. F., and Kroemer, G. (2001) Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3, E255-E263
167. Paschen, W. (2001) Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states. Cell Calcium 29, 1-11
168. Nakagawa, T., and Yuan, J. (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150, 887-894
169. Utz, P. J., and Anderson, P. (2000) Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ. 7, 589-602
170. Mashima, T., Naito, M., and Tsuruo, T. (1999) Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 18, 2423-2430
171. Janicke, R. U., Ng, P., Sprengart, M. L., and Porter, A. G. (1998) Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273, 15540-15545
172. 2+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). Adv. Enzyme Regul. 19, 407-424
173. Asanuma, M., Hayashi, T., Ordonez, S. V., Ogawa, N., and Cadet, J. L. (2000) Direct interactions of methamphetamine with the nucleus. Brain Res. 80, 237-243
174. Patil, C., and Walter, P. (2001) Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr. Opin. Cell Biol. 13, 349-355
175. Ron, D., and Habener, J. F. (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6, 439-453
176. Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Light-foot, R. T., Remotti, H., Stevens, J. L., and Ron, D. (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12, 982-995
177. 2+ stores. J. Biol. Chem. 277, 9219-9225
178. Hirata, H., Asanuma, M., and Cadet, J. L. (1998) Superoxide radicals are mediators of the effects of methamphetamine on Zif268 (Egr-1, NGFI-A) in the brain: evidence from using CuZn superoxide dismutase transgenic mice. Brain Res. 58, 209-216
179. Sheng, P., Wang, X. B., Ladenheim, B., Epstein, C., and Cadet, J. L. (1996) AP-1 DNA-binding activation by methamphetamine involves oxidative stress. Synapse 24, 213-217
180. Kaina, B., Haas, S., and Kappes, H. (1997) A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs. Cancer Res. 57, 2721-2731
181. Lackinger, D., Eichhorn, U., and Kaina, B. (2001) Effect of ultraviolet light, methyl methanesulfonate and ionizing radiation on the genotoxic response and apoptosis of mouse fibroblasts lacking c-Fos, p53 or both. Mutagenesis 16, 233-241
182. Johnson, R. S., Spiegelman, B. M., and Papaioannou, V. (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71, 577-586
183. Schreiber, M., Baumann, B., Cotten, M., Angel, P., and Wagner, E. F. (1995) Fos is an essential component of the mammalian UV response. EMBO J. 14, 5338-5349
184. Cadet, J. L., McCoy, M. T., and Ladenheim, B. (2002) Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: evidence from CDNA array analyses. Synapse 44, 211-226
185. Reiter, C. D., Teng, R. J., and Beckman, J. S. (2000) Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J. Biol. Chem. 275, 32460-32466
186. Burney, S., Caulfield, J. L., Niles, J. C., Wishnok, J. S., and Tannenbaum, S. R. (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 424, 37-49
187. Nilsen, H., and Krokan, H. E. (2001) Base excision repair in a network of defence and tolerance. Carcinogenesis 22, 987-998
188. Petit, C., and Sancar, A. (1999) Nucleotide excision repair: from E. coli to man. Biochimie 81, 15-25
189. Ramana, C. V., Boldogh, I., Izumi, T., and Mitra, S. (1998) Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc. Natl. Acad. Sci. USA 95, 5061-5066
190. Bhattacharya, R., and Beck, D. J. (2002) Survival and SOS induction in cisplatin-treated Escherichia coli deficient in Pol II, RecBCD and RecFOR functions. DNA Repair (Amst.) 1, 955-966
191. Fornace, A. J., Jr., Zmudzka, B., Hollander, M. C., and Wilson, S. H. (1989) Induction of beta-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells. Mol. Cell Biol. 9, 851-853
192. Montecucco, A., Savini, E., Biamonti, G., Stefanini, M., Focher, F., and Ciarrocchi, G. (1995) Late induction of human DNA ligase I after UV-C irradiation. Nucleic Acids Res. 23, 962-966
193. Mogi, M, Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., and Nagatsu, T. (1999) Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci. Lett. 270, 45-48
194. Caldwell, M. A., He, X., Wilkie, N., Pollack, S., Marshall, G., Wafford, K. A., and Svendsen, C. N. (2001) Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat. Biotechnol. 19, 475-479
195. Salehi, A., Delcroix, J. D., and Mobley, W. C. (2003) Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci. 26, 73-80
196. Sullivan, A. M., Opacka-Juffry, J., Hotten, G., Pohl, J., and Blunt, S. B. (1997) Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease. Neurosci. Lett. 233, 73-76
197. Cass, W. A. (1996) GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. J. Neurosci. 16, 8132-8139
198. Cass, W. A., Manning, M. W., and Bailey, S. L. (2000) Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine. Ann. N. Y. Acad. Sci. 914, 127-136
199. Melega, W. P., Lacan, G., Desalles, A. A., and Phelps, M. E. (2000) Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey. Synapse 35, 243-249
200. Friedman, S. D., Castaneda, E., and Hodge, G. K. (1998) Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav. 61, 35-44
201. Harvey, D. C., Lacan, G., Tanious, S. P., and Melega, W. P. (2000) Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res. 871, 259-270
202. Bakhit, C., Morgan, M. E., Peat, M. A., and Gibb, J. W. (1981) Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology 20, 1135-1140
203. Melega, W. P., Raleigh, M.J., Stout, D. B., Lacan, G., Huang, S. C., and Phelps, M. E. (1997) Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res. 766, 113-120
204. Ricaurte, G. A., Schuster, C. R., and Seiden, L. S. (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193, 153-163
205. Cass, W. A., and Manning, M. W. (1999) Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J. Neurosci. 19, 7653-7660
206. Nestler, E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128
207. Figueredo-Cardenas, G., Harris, C. L., Anderson, K. D., and Reiner, A. (1998) Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. Exp. Neurol. 149, 356-372
208. Ashkenazi, A., and Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308